XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

79 hedge funds and large institutions have $351M invested in Xenon Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 11 closing their positions.

Holders
79
Holders Change
+9
Holders Change %
+12.86%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
20
Increased
25
Reduced
10
Closed
11
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$1K

Top Buyers

1
BI
1
BVF Inc
California
$44.1M
2
O
2
OrbiMed
New York
$31.3M
3
BBA
3
Baker Bros. Advisors
New York
$10M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$27.6M
5
UBS AM
5
UBS AM
Illinois
$4.57M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$0
2
ACM
2
Aquilo Capital Management
California
$0
3
VC
3
Vivo Capital
California
$0
4
BCM
4
Burrage Capital Management
Massachusetts
$0
5
IC
5
Ikarian Capital
Texas
$3.74M
Name Market Value Shares Shares
Change 		Shares
Change %
BI
1
BVF Inc
California
$44.1M 3,516,851 +842,513 +32%
ACA
2
Avoro Capital Advisors
New York
$35.1M 2,800,000 +28,000 +1%
O
3
OrbiMed
New York
$31.3M 2,497,917 +835,105 +50%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$27.6M 2,199,054 +611,518 +39%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$25.4M 2,025,000 – –
EAM
6
Eventide Asset Management
Massachusetts
$16M 1,274,100 – –
Capital International Investors
7
Capital International Investors
California
$13.2M 1,055,726 – –
Renaissance Technologies
8
Renaissance Technologies
New York
$13M 1,035,277 +247,200 +31%
NMC
9
NEA Management Company
Maryland
$12.4M 992,107 – –
Capital World Investors
10
Capital World Investors
California
$12.1M 963,500 – –
BBA
11
Baker Bros. Advisors
New York
$10M 799,102 +799,102 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$9.97M 794,689 +118,813 +18%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$8.27M 659,404 +74,351 +13%
BC
14
Boxer Capital
California
$7.52M 600,000 – –
PHP
15
Parkman Healthcare Partners
Connecticut
$7.4M 590,267 – –
ACP
16
Acuta Capital Partners
California
$6.49M 517,500 -111,000 -18%
RSCM
17
Rock Springs Capital Management
Maryland
$6.47M 515,711 +15,711 +3%
DCM
18
Driehaus Capital Management
Illinois
$5.82M 464,233 +1,901 +0.4%
Citadel Advisors
19
Citadel Advisors
Florida
$4.89M 390,260 -115,769 -23%
UBS AM
20
UBS AM
Illinois
$4.57M 364,757 +364,757 New
DCM
21
DAFNA Capital Management
California
$4.35M 346,535 – –
GTC
22
Ghost Tree Capital
New York
$4.08M 325,000 – –
IC
23
Ikarian Capital
Texas
$3.74M 298,173 -145,409 -33%
SCM
24
Soleus Capital Management
Connecticut
$3.15M 250,897 +237,669 +1,797%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$2.63M 209,618 +67,110 +47%
1
2 3 4